FDA advisory committee reviews effectiveness of common ingredient in some nasal decongestants

Singapore News News

FDA advisory committee reviews effectiveness of common ingredient in some nasal decongestants
Singapore Latest News,Singapore Headlines
  • 📰 ABC
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 51%

An FDA advisory committee is meeting to discuss the effectiveness of the oral formulation of a very common nasal decongestant, phenylephrine.

September 11, 2023, 4:30 PMJeff Greenberg/Universal Images/Getty Images

All over-the-counter medications hold a designation as "generally recognized as safe and effective" by the FDA, but clinical trials have found that oral phenylephrine, or PE, does not improve nasal congestion any more than a placebo at the dosage marked for over-the-counter use. In a public statement, the Consumer Healthcare Products Association, which represents manufacturers of over-the-counter-drugs, expressed concern that removing PE from the market could delay consumers from seeking care or may overburden the health care system by seeking treatment for a minor illness if adequate over-the-counter treatments cannot be accessed.

Sutton said that when it comes to treating cold and flu symptoms like nasal congestion, sometimes less is more.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ABC /  🏆 471. in US

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

SA germ-zapping robot-maker Xenex clears major FDA hurdleSA germ-zapping robot-maker Xenex clears major FDA hurdleThe U.S. Food and Drug Administration has granted Xenex Disinfection Services a De Novo authorization for its LightStrike+ device.
Read more »

FDA approves updated Covid vaccines from Pfizer and Moderna as hospitalizations riseFDA approves updated Covid vaccines from Pfizer and Moderna as hospitalizations riseThe Biden administration said it expects the new Pfizer and Moderna vaccines targeting the omicron variant XBB.1.5 to be available in mid-September.
Read more »

FDA Approves Newest Covid-19 BoostersFDA Approves Newest Covid-19 BoostersVaccine specialists say the updated shots should protect against strains now circulating. The boosters should be available within days..
Read more »

FDA okays new coronavirus vaccine as respiratory illness season nearsFDA okays new coronavirus vaccine as respiratory illness season nearsThe covid vaccines are expected to be available later this week after the Centers for Disease Control and Prevention signs off.
Read more »

Pfizer and Moderna updated COVID vaccines approved by FDAPfizer and Moderna updated COVID vaccines approved by FDAThe U.S. Food and Drug Administration on Monday approved updated mRNA COVID vaccines from Moderna Inc. and Pfizer Inc. People five years of age and older are...
Read more »



Render Time: 2025-03-06 14:36:01